I learned something new today.
“Osteosarcoma is the third most common cancer in young people, yet during the past 20 years little research has been carried out into developing improved therapies, and survival rates have remained unchanged with only 54 per cent of patients alive after five years, says Robert Grimer, a consultant orthopaedic oncologist at The Royal Orthopaedic Hospital NHS Trust in Birmingham.”
A few other sites have quoted 65% as a survival rate, but I have yet to find anything higher.
If or when this blog generates any kind of income, I’m going to divide it evenly between the Pediatric Cancer Foundation and the Sam Loeb College Scholarship Fund.
February 17th, 2009 at 11:18 pm
Good for you!